Apellis Pharmaceuticals Inc XNAS: APLS

Apellis Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Apellis Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Apellis Pharmaceuticals Inc
Rating: 1.1509445
Author: Trendlyne DVM scores

Weak Stock

Download real time

18.20 0.04 (0.22%)

Near 52W Low of $17.48

2.1M XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

Low Financial Strength

27.8 / 100

Expensive Valuation

12.5 / 100

Technically Bearish

24.0 / 100

Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

42

1Yr Price target upside is 133%

20 analysts

Apellis Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Apellis Pharmaceuticals Inc FAQ

How is Apellis Pharmaceuticals Inc today?

Apellis Pharmaceuticals Inc today is trading in the green, and is up by 0.22% at 18.20.

How has Apellis Pharmaceuticals Inc performed historically?

Apellis Pharmaceuticals Inc is currently trading up 0.22% on an intraday basis. In the past week the stock fell -6.28%. stock has been down -39.21% in the past quarter and fell -61.69% in the past year. You can view this in the overview section.